-
1
-
2
-
3
-
4
-
5
-
6
-
7
Efficacy and safety of using Etelcalcetide for controlling secondary hyperparathyroidism
منشور في 2024"…</p><h3>Results</h3><p dir="ltr">Patients within the PTH target range of 150 to 500pg/ml improved from 8% in June 2021 (on Cinacalcet) to 54% in June 2023 (on Etelcalcetide) (p=0 .0032) while patients with PTH above 1,000pg/ml decreased from 50% to 4% during the same period (p=0.00001) (Figure 2). …"